- Division of Neuroscience, Development and Aging – DNDA
- Review Branch:
- Clinical Neuroscience – CN
- Study Section:
- Clinical Neuroimmunology and Brain Tumors – CNBT
Dr. Aleksey Kazantsev received his Ph.D. in biochemistry, molecular biology and biotechnology from the University of North Carolina at Chapel Hill; his mentor was Nobel Laureate in Chemistry Dr. Aziz Sancar. Dr. Kazantsev conducted his postdoctoral training at Massachusetts Institute of Technology, where he focused on the investigation of basic and translational research of Huntington’s disease (HD) and other neurodegenerative disorders in the laboratory of Dr. David Housman, who discovered the HD gene, the first identified human disease gene. Dr. Kazantsev came to CSR from Harvard Medical School, after having risen to the rank of associate professor in the Department of Neurology, Massachusetts General Hospital (MGH). During his tenure at MGH his research was centered to study mechanisms of neurodegeneration and neuroprotection, with emphasis on discovery new therapeutic approach.